抗MCV抗体在类风湿性关节炎中的进展
Progress of Anti-Mutated Citrullinated Vimentin in Rheumatoid Arthritis
摘要: 类风湿关节炎是慢性自身免疫学疾病，可侵蚀多关节，因多脏器受累、致畸，故早期合理化治疗至关重要，其发生基础为免疫损害，抗体可帮助早期诊断。抗突变型瓜氨酸波形蛋白抗体(Anti-Mutated Citrullinated Vimentin, MCV)属于抗瓜氨酸化蛋白抗体家族，在诊断类风湿性关节炎中的灵敏度和特异度与抗环状瓜氨酸抗体类似，同时抗MCV抗体阳性亦可预测关节破坏程度，可用于早期诊断及预后评估。本文就抗MCV抗体在类风湿性关节炎中的相关研究作一综述。
Abstract: Rheumatoid arthritis is a chronic autoimmunological disease that can erode multiple joints. Due to the involvement of multiple organs and teratogenesis, early rational treatment is crucial. Its occur-rence is based on immune damage and antibodies can help early diagnosis. Anti-mutated citrulli-nated vimentin (MCV) belongs to the anti-citrullinated protein antibody family, and its sensitivity and specificity in the diagnosis of rheumatoid arthritis are similar to that of anti-cyclic citrullinated antibodies. Meanwhile, positive anti-MCV antibodies can also predict the degree of joint destruction, and can be used for early diagnosis and prognosis assessment. This article reviews the research progress of anti-MCV antibody in rheumatoid arthritis.
文章引用：田艳南, 帕丽达·阿布利孜. 抗MCV抗体在类风湿性关节炎中的进展[J]. 临床医学进展, 2023, 13(12): 20305-20310. https://doi.org/10.12677/ACM.2023.13122858

参考文献

[1] Cush, J.J. (2022) Rheumatoid Arthritis: Early Diagnosis and Treatment. Rheumatic Disease Clinics of North America, 48, 537-547. [Google Scholar] [CrossRef] [PubMed]
[2] 方霖楷, 黄彩鸿, 谢雅, 等. 类风湿关节炎患者实践指南[J]. 中华内科杂志, 2020, 59(10): 772-780.
[3] 杨丽, 刘荣华, 黄四碧, 等. 类风湿性关节炎的发病机制及治疗药物研究进展[J]. 中国药房, 2021, 32(17): 2154-2159.
[4] 耿研, 谢希, 王昱, 等. 类风湿关节炎诊疗规范[J]. 中华内科杂志, 2022, 61(1): 51-59.
[5] Nigm, D.A., Abdel-Lateef, H.H., Hashim, J., et al. (2022) Antibodies against a Mutated Citrullinated Vimentin in Patients with Rheumatoid arthritis. Egyptian Journal of Immunology, 29, 184-194. [Google Scholar] [CrossRef] 
[6] Despres, N., Boire, G., Lopez-Longo, F.J., et al. (1994) The Sa System: A Novel Antigen-Antibody System Specific for Rheumatoid Arthritis. The Journal of Rheumatology, 21, 1027-1033.
[7] Menard, H.A., Lapointe, E., Rochdi, M.D., et al. (2000) Insights into Rheumatoid Arthritis Derived from the Sa Immune System. Arthritis Research, 2, 429-432. [Google Scholar] [CrossRef] [PubMed]
[8] Vossenaar, E.R., Despres, N., Lapointe, E., et al. (2004) Rheumatoid Arthritis Specific Anti-Sa Antibodies Target Citrullinated Vimentin. Arthritis Research & Therapy, 6, R142-R150. [Google Scholar] [CrossRef] 
[9] Bang, H., Egerer, K., Gauliard, A., et al. (2007) Mutation and Citrullination Modifies Vimentin to a Novel Autoantigen for Rheumatoid Arthritis. Arthri-tis & Rheumatology, 56, 2503-2511. [Google Scholar] [CrossRef] [PubMed]
[10] Kuna, A.T. (2012) Mutated Citrullinat-ed Vimentin Antibodies in Rheumatoid Arthritis. Clinica Chimica Acta, 413, 66-73. [Google Scholar] [CrossRef] [PubMed]
[11] Wu, R., Shovman, O., Zhang, Y., et al. (2007) Increased Prevalence of Anti-Third Generation Cyclic Citrullinated Peptide Antibodies in Patients with Rheumatoid Arthritis and CREST Syn-drome. Clinical Reviews in Allergy & Immunology, 32, 47-56. [Google Scholar] [CrossRef] 
[12] Zhu, J.N., Nie, L.Y., Lu, X.Y., et al. (2019) Meta-Analysis: Compared with Anti-CCP and Rheumatoid Factor, Could Anti-MCV Be the Next Biomarker in the Rheumatoid Arthritis Classification Criteria? Clinical Chemistry and Laboratory Medicine, 57, 1668-1679. [Google Scholar] [CrossRef] [PubMed]
[13] Tan, L., Gong, Y., Zhang, Q., et al. (2021) Clinical Value of Detecting Anti-Mutated Citrullinated Vimentin, Anti-Cyclic Citrullinated Peptide, Red Cell Distribution Width and 25-Hydroxyvitamin D in the Diagnosis of Rheumatoid Arthritis. Laboratory Medicine, 52, 80-85. [Google Scholar] [CrossRef] [PubMed]
[14] Barouta, G., Katsiari, C.G., Alexiou, I., et al. (2017) Anti-MCV An-tibodies Predict Radiographic Progression in Greek Patients with Very Early (<3 Months Duration) Rheumatoid Arthri-tis. Clinical Rheumatology, 36, 885-894. [Google Scholar] [CrossRef] [PubMed]
[15] Hu, T., Liu, Y., Tan, L., et al. (2021) Value of Serum Collagen Triple Helix Repeat Containing-1 (CTHRC1) and 14-3-3η Protein Compared to Anti-CCP Antibodies and Anti-MCV Antibodies in the Diagnosis of Rheumatoid Arthritis. British Journal of Biomedical Science, 78, 67-71. [Google Scholar] [CrossRef] [PubMed]
[16] Martinez, G., Feist, E., Martiatu, M., et al. (2020) Autoanti-bodies against a Novel Citrullinated Fibrinogen Peptide Related to Smoking Status, Disease Activity and Therapeutic Response to Methotrexate in Cuban Patients with Early Rheumatoid Arthritis. Rheumatology International, 40, 1873-1881. [Google Scholar] [CrossRef] [PubMed]
[17] Ishigooka, N., Fujii, T., Abe, H., et al. (2020) Pre-dicting Factors for Disappearance of Anti-Mutated Citrullinated Vimentin Antibodies in Sera of Patients with Rheumatoid Arthritis. Modern Rheumatology, 30, 450-457. [Google Scholar] [CrossRef] [PubMed]
[18] Reyes-Castillo, Z., Palafox-Sanchez, C.A., Parra-Rojas, I., et al. (2015) Comparative Analysis of Autoantibodies Targeting Peptidylarginine Deiminase Type 4, Mutated Citrullinated Vimentin and Cyclic Citrullinated Peptides in Rheumatoid Arthritis: Associations with Cytokine Profiles, Clinical and Genetic Features. Clinical and Experimental Immunology, 182, 119-131. [Google Scholar] [CrossRef] [PubMed]
[19] 赵浩宇. 抗MCV抗体滴度与类风湿关节炎患者系统受累和疾病复发的相关性[J]. 检验医学与临床, 2022, 19(11): 1518-1521.
[20] 邓皓莹, 文振华, 凌青, 等. 抗MCV抗体与RANKL、OPG、TRACP-5b及RA疾病活动度的相关性研究[J]. 中国骨质疏松杂志, 2021, 27(5): 713-716.
[21] Gonzalez-Lopez, L., Rocha-Munoz, A.D., Ponce-Guarneros, M., et al. (2014) Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vi-mentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis. Journal of Immunology Re-search, 2014, Article ID: 536050. [Google Scholar] [CrossRef] [PubMed]
[22] 余晓萍, 黎村艳, 张蜀澜, 等. 抗突变型瓜氨酸波形蛋白抗体对类风湿关节炎诊断的补充价值[J]. 中华检验医学杂志, 2019, 42(4): 287-292.
[23] 梁金, 殷寒秋, 殷松楼. 抗CCP抗体、抗MCV抗体联合检测在类风湿关节炎合并间质性肺病中的意义[J]. 医学研究杂志, 2022, 51(1): 120-124.
[24] 苗珍珍, 殷松楼, 殷寒秋. 人血清抗MCV-Ab与类风湿关节炎合并间质性肺病的关系[J]. 河北医药, 2018, 40(14): 2095-2098.
[25] Norouzi, S., Javinani, A., Aminorroaya, A., et al. (2020) An-ti-Modified Citrullinated Vimentin Antibody: A Novel Biomarker Associated with Cardiac Systolic Dysfunction in Pa-tients with Rheumatoid Arthritis. BMC Cardiovascular Disorders, 20, Article No. 390. [Google Scholar] [CrossRef] [PubMed]
[26] Lindenberg, L., Spengler, L., Bang, H., et al. (2015) Restrictive IgG Antibody Response against Mutated Citrullinated vimentin Predicts Response to Rituximab in Patients with Rheu-matoid Arthritis. Arthritis Research & Therapy, 17, 206. [Google Scholar] [CrossRef] [PubMed]
[27] Syversen, S.W., Goll, G.L., van der Heijde, D., et al. (2010) Pre-diction of Radiographic Progression in Rheumatoid Arthritis and the Role of Antibodies against Mutated Citrullinated Vimentin: Results from a 10-Year Prospective Study. Annals of the Rheumatic Diseases, 69, 345-351. [Google Scholar] [CrossRef] [PubMed]
[28] 陈楚涛, 张学培, 杨莉娟, 等. 抗突变型瓜氨酸波形蛋白抗体对类风湿关节炎患者一年关节影像学进展的预测价值[J]. 中华内科杂志, 2021, 60(2): 128-133.
[29] Avdeeva, A.S., Aleksandrova, E.N., Novikov, A.A., et al. (2014) The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis. International Journal of Rheumatology, 2014, Arti-cle ID: 464585. [Google Scholar] [CrossRef] [PubMed]
[30] Alessandri, C., Agmon-Levin, N., Conti, F., et al. (2017) Anti-Mutated Citrullinated Vimentin Antibodies in Antiphospholipid Syndrome: Diagnostic Value and Relation-ship with Clinical Features. Immunology Research, 65, 524-531. [Google Scholar] [CrossRef] [PubMed]
[31] Dalmady, S., Kiss, M., Kepiro, L., et al. (2013) Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis than in Patients with Psoria-sis Vulgaris. Clinical and Developmental Immunology, 2013, Article ID: 474028. [Google Scholar] [CrossRef] [PubMed]
[32] Tesija-Kuna, A., Grazio, S., Miler, M., et al. (2010) Antibodies Target-ing Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis. Clinical Rheumatology, 29, 487-493. [Google Scholar] [CrossRef] [PubMed]
[33] 张露月, 史丽璞, 茹晋丽, 等. 抗突变型瓜氨酸波形蛋白抗体抗环瓜氨酸肽抗体对类风湿关节炎与幼年特发性关节炎患者诊断价值的比较[J]. 中华风湿病学杂志, 2018, 22(3): 176-180.
[34] 刘润荣, 李艳青, 马秀芬, 等. 抗突变型瓜氨酸波形蛋白抗体在幼年特发性关节炎中的临床价值[J]. 潍坊医学院学报, 2014(1): 18-20.
[35] Beltrami, A., Rossmann, M., Fiorillo, M.T., et al. (2008) Citrulli-nation-Dependent Differential Presentation of a Self-Peptide by HLA-B27 Subtypes. Journal of Biological Chemistry, 283, 27189-27199. [Google Scholar] [CrossRef] 
[36] Bodnar, N., Szekanecz, Z., Prohaszka, Z., et al. (2012) Anti-Mutated Citrullinated Vimentin (Anti-MCV) and Anti-65 kDa Heat Shock Protein (Anti-hsp65): New Biomarkers in Ankylosing Spondylitis. Joint Bone Spine, 79, 63-66. [Google Scholar] [CrossRef] [PubMed]
[37] 范见佩, 汤文辉, 钟运华, 等. 93例强直性脊柱炎患者抗突变型瓜氨酸波形蛋白抗体的检测[J]. 国际检验医学杂志, 2014(10): 1352-1353.

为你推荐